Abstract
Angiogenesis, or generation of new blood vessels from pre-existing vessels, is an integral part of many physiological or pathological processes, including tumor growth. Physiological angiogenesis is a complex process controlled by different proangiogenic as well as antiangiogenic factors. For angiogenic induction, the balance between these pro- and anti-angiogenic factors in the microenvironment has to shift in favor of proangiogenic factors, either by upregulation of these pro-angiogenic factors or by downregulation of angiogenic inhibitors. Proinflammatory cytokines, such as IL-1 and TNFα , were found to be major pro-angiogenic stimuli of both physiological and pathological angiogenesis. The IL-1 family consists of pleiotropic proinflammatory and immunoregulatory cytokines, namely, IL-1α and IL-1β , and one antagonistic protein, the IL-1 receptor antagonist (IL-1Ra), which binds to IL-1 receptors without transmitting an activation signal and represents a physiological inhibitor of preformed IL-1. Previously, we described an important role for microenvironment IL-1, mainly IL-1β , in tumor angiogenesis. In this chapter, we analyze the role of microenvironment host- and tumor cell-derived IL-1 on angiogenesis and the role of inflammation in pathological angiogenesis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Apte, R.N., Dotan, S., Elkabets, M., White, M.R., Reich, E., Carmi, Y., Song, X., Dvorkin, T., Krelin, Y. and Voronov, E. (2006a) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25, 387–408.
Apte, R.N., Krelin, Y., Song, X., Dotan, S., Recih, E., Elkabets, M., Carmi, Y., Dvorkin, T., White, R.M., Gayvoronsky, L., Segal, S. and Voronov, E. (2006b) Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur. J. Cancer 42, 751–759.
Apte, R.N. and Voronov, E. (2002) Interleukin-1-a major pleiotropic cytokine in tumor-host interactions. Semin. Cancer Biol. 12, 277–290.
Asahara, T. and Kawamoto, A. (2004) Endothelial progenitor cells for postnatal vasculogenesis. Am. J. Physiol. Cell Physiol. 287, C572–579.
Balkwill, F. (2002) Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 13, 135–141.
Bar, D., Apte, R.N., Voronov, E., Dinarello, C.A. and Cohen, S. (2004) A continuous delivery system of IL-1Ra reduces angiogenesis and inhibits tumor development. FASEB J. 18, 161–163.
Ben-Av, P., Crofford, L.J., Wilder, R.L. and Hla, T. (1995) Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 372, 83–87.
Carmeliet, P. (2003) Angiogenesis in health and disease. Nat. Med. 9, 653–660.
Carmeliet, P. and Jain, R.K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249–257.
Dinarello, C.A. (1996) Biologic basis for interleukin-1 in disease. Blood 87, 2095–2147.
El Awad, B., Kreft, B., Wolber, E.M., Hellwig-Burgel, T., Metzen, E., Fandrey, J. and Jelkmann, W. (2000) Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int. 58, 43–50.
Elaraj, D.M., Weinreich, D.M., Varghese, S., Puhlmann, M., Hewitt, S.M., Carroll, N.M., Feldman, E.D., Turner, E.M. and Alexander, H.R. (2006) The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin. Cancer Res. 12, 1088–1096.
Fiedler, U. and Augustin, H.G. (2006) Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 27, 552–558.
Folkman, J. (2003) Fundamental concepts of the angiogenic process. Curr. Mol. Med. 3, 643–651.
Folkman, J. and D’Amore, P.A. (1996) Blood vessel formation: what is its molecular basis? Cell 87, 1153–1155.
Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364.
Ishikawa, M. and Asahara, T. (2004) Endothelial progenitor cell culture for vascular regeneration. Stem Cells Dev. 13, 344–349.
Jung, Y.D., Liu, W., Reinmuth, N., Ahmad, S.A., Fan, F., Gallick, G.E. and Ellis, L.M. (2001) Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway. Angiogenesis 4, 155–162.
Krelin, Y., Voronov, E., Dotan, S., Elkabets, M., Reich, E., Fogel, M., Huszar, M., Iwakura, Y., Segal, S., Dinarello, C.A. and Apte, R.N. (2007) Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res. 67, 1062–1071.
Mantovani, A. and Dejana, E. (1989) Cytokines as communication signals between leukocytes and endothelial cells. Immunol. Today 10, 370–375.
Moldovan, N. I. and Asahara, T. (2003) Role of blood mononuclear cells in recanalization and vascularization of thrombi: past, present, and future. Trends Cardiovasc. Med. 13, 265–269.
Murayama, T., Tepper, O. M., Silver, M., Ma, H., Losordo, D.W., Isner, J.M., Asahara, T. and Kalka, C. (2002) Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp. Hematol. 30, 967–972.
Rafii, S., Lyden, D., Benezra, R., Hattori, K. and Heissig, B. (2002) Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat. Rev. Cancer 2, 826–835.
Song, X., Krelin, Y., Dvorkin, T., Bjorkdahl, O., Segal, S., Dinarello, C.A., Voronov, E. and Apte, R.N. (2005) CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1β -secreting cells. J. Immunol. 175, 8200–8208.
Song, X., Voronov, E., Dvorkin, T., Fima, E., Cagnano, E., Benharroch, D., Shendler, Y., Bjorkdahl, O., Segal, S., Dinarello, C.A. and Apte, R.N. (2003) Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J. Immunol. 171, 6448–6456.
Voronov, E., Shouval, D.S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C.A. and Apte, R.N. (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl. Acad. Sci. USA 100, 2645–2650.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this paper
Cite this paper
Voronov, E., Carmi, Y., Apte, R.N. (2007). Role of IL-1-Mediated Inflammation in Tumor Angiogenesis. In: Shurin, M.R., Smolkin, Y.S. (eds) Immune-Mediated Diseases. Advances in Experimental Medicine and Biology, vol 601. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72005-0_28
Download citation
DOI: https://doi.org/10.1007/978-0-387-72005-0_28
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72004-3
Online ISBN: 978-0-387-72005-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)